ResMed (RMD) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $196.50 +2.74%
EPS Growth %: +13.3%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +13.3%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.43, $0.11 better than the analyst estimate of $2.32. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- ConectivGlobal launches ConeqtX and MyLife Wellness platforms
- Intel-backed SambaNova in talks for funding at $10 billion valuation - The Information
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
